Archives for November 6, 2002

← 2002

Biotech firm starts trials on allergy treatment

Evolutec, the British biotechnology company which develops novel therapeutic products from parasites, is to begin Phase I and II clinical trials with rEV131, its treatment for allergic and inflammatory diseases.

Cannabis medicines could hit UK next year

Cannabis-based medicine could be on the UK market as early as 2003, according to GW Pharmaceuticals, the UK company developing cannabis-based prescription medicines, which this week released results from four Phase III clinical trials.

UK team gets funding for resveratrol research

The University of Leicester in the UK has been selected as one of the first centres in the world to trial a revolutionary new cancer prevention drug, based on a natural compound found in red wine.